Welcome
Clearer Decisions. More Personalised Cancer Care.
Evidence-based medical oncology, precision oncology and structured second opinions for patients and families navigating complex cancer decisions.
I am Dr Raman Narang, a medical and hemato-oncologist with a clinical focus on precision oncology, cancer genetics and personalised cancer treatment in the elderly patients as well as the young ones.
Cancer care often involves difficult decisions; whether chemotherapy is necessary, whether molecular testing may change treatment, whether a proposed treatment is appropriate, or whether another option should be considered. My role is to help patients and families understand these decisions clearly and develop a treatment strategy based on the cancer type, stage, biology, overall health and individual priorities.
My areas of interest include solid tumours, hematological malignancies, immunotherapy, targeted therapy, molecular diagnostics and complex second opinions.
Specializing in biomarker-driven cancer treatment using molecular profiling, targeted therapy, and immunotherapy to deliver personalized and evidence-based care.
Start Here
Newly diagnosed with cancer?
Understand the diagnosis, stage and next steps.
Considering a second opinion?
Get a structured review of reports and treatment options.
Have an NGS or molecular report?
Understand whether the findings are clinically relevant.
Featured In: Financial Express • Hindustan Times • Indian Express • Republic World • Times Now • BBC
Clinical Focus
Precision Oncology & Molecular Profiling
Treatment selection based on tumor biology and genomic markers.
Cancer Genetics & Hereditary Risk
Evaluation of inherited cancer risk and family-based screening strategies.
Immunotherapy & Targeted Therapy
Use of biomarker-guided therapies aligned with international standards.
Structured Second Opinion
Independent review of diagnosis, staging, and treatment strategy.
Cancer Treatment Is Not One-Size-Fits-All
Two patients with the same cancer may not always require the same treatment. The most appropriate plan may depend on the tumour subtype, stage, molecular characteristics, previous treatment, age, overall health and the patient’s own goals.
My approach combines established oncology guidelines with careful interpretation of pathology, imaging and molecular information. Precision oncology is used where it can genuinely influence treatment—not simply because a test is available.
Frequently Asked Questions
What is precision oncology?
Precision oncology involves tailoring cancer treatment based on molecular and genetic characteristics of the tumor. Biomarker testing helps identify whether targeted therapy or immunotherapy may be effective.
When should a second opinion be considered?
A second opinion is useful at diagnosis, before starting treatment, before major surgery, or when treatment options are unclear. A structured review can refine treatment decisions.
Can cancer treatment be offered safely in older adults?
Yes. Treatment decisions are based on overall fitness rather than age alone. A structured geriatric oncology approach helps optimize safety and outcomes.
Does being younger make cancer treatment easier?
No. Younger patients may have different disease biology and unique concerns such as fertility, long-term side effects, and survivorship planning.
Cancer treatment should be guided by disease biology, functional status, and patient-specific goals rather than age-based assumptions.
When Should You See a Medical Oncologist?
A medical oncologist plays a central role in diagnosing, staging, and planning treatment for cancer. Early consultation ensures that treatment decisions are structured, evidence-based, and aligned with the latest advances in precision oncology.
- New cancer diagnosis → To understand stage, prognosis, and treatment options
- Conflicting medical opinions → To obtain a structured second opinion
- Consideration of chemotherapy, immunotherapy, or targeted therapy
- Advanced or metastatic cancer → For systemic treatment planning
- Need for molecular or genetic testing → To guide personalized therapy
- Before major surgery or high-risk treatment decisions
Early and informed decision-making can significantly influence both treatment outcomes and long-term quality of life.
Precision Oncology Approach
Modern cancer treatment is no longer uniform. Precision oncology focuses on understanding the unique biology of each patient’s cancer to guide individualized treatment decisions.
- Molecular profiling → Identifying actionable mutations such as EGFR, ALK, HER2, and others
- Cancer genetics → Evaluating inherited risk through germline testing when appropriate
- Biomarker-driven therapy → Selecting targeted therapy or immunotherapy based on tumor characteristics
- Structured treatment planning → Integrating pathology, imaging, and molecular data
- Multidisciplinary coordination → Aligning systemic therapy with surgery and radiation
This approach allows treatment to be tailored—not only to the disease, but also to the individual—improving outcomes while minimizing unnecessary toxicity.
How Treatment Decisions Are Made in Modern Oncology
Cancer treatment decisions are based on a structured clinical framework that integrates disease stage, tumor biology, patient factors, and available evidence. This ensures that each treatment plan is individualized and clinically justified.
- If the cancer is early-stage and localized
→ Surgery with or without adjuvant therapy is typically considered - If actionable molecular markers are present
→ Targeted therapy may be preferred over conventional chemotherapy - If immunotherapy biomarkers (PD-L1, MSI, TMB) are significant
→ Immunotherapy becomes an important component of treatment - If the patient is elderly or medically frail
→ Treatment intensity is adjusted to balance efficacy and safety - If multiple treatment strategies are available
→ A structured second opinion helps optimize sequencing and outcomes
This decision-making process reflects the shift from standardized protocols to personalized cancer care based on precision oncology principles.